You are here: Industry Insights > biomanufacturing

News List

Global Demand For COVID-19 Products Presents Huge Opportunities for the Biomanufacturing Sector Sarah Harding
November 27, 2020
In 2020, as part of the fight against COVID-19, we have witnessed incredible collaborations between biotech, big pharma, academia and not-for-profit organizations, all working together to develop treatments and vaccines at record speed.
Genomic Vision Launches HexaCard, a New Service to CharacterizeCell Lines Used for Biomanufacturing and Cell & Gene Therapy PharmaSources
July 18, 2023
Genomic Vision Launches HexaCard, a New Service to CharacterizeCell Lines Used for Biomanufacturing and Cell & Gene Therapy.
BioGenes and Alphalyse Collaborate to Optimize ELISA Reagent Characterization for Biomanufacturing b3cnewswire
February 10, 2022
2D gel analytics and LC-MS are the most common methods for HCP reagent characterization, and should ideally both be used to maximize...
Gates biomanufacturing facility announces agreement with Nkarta EuropeanPharmaceuticalReview
November 08, 2021
The Gates Biomanufacturing Facility (GBF) has announced a continued strategic agreement with Nkarta to manufacture clinical supply of therapeutic natural killer cells.
Amgen Investing $550M in New Biomanufacturing Facility contractpharma
August 06, 2021
Amgen has unveiled plans to build a new $550 million biologics manufacturing facility in Holly Springs, NC, creating 355 jobs along the way.
Resilience Bolsters Canadian Biomanufacturing Site contractpharma
May 24, 2021
National Resilience, Inc., said that the Government of Canada will invest $163.8 million, through the Strategic Innovation Fund, in the company’s Ontario-based subsidiary Resilience Biotechnologies Inc. (RBI) to modernize and expand production capacity.
Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie contractpharma
March 08, 2021
Pharmaron Beijing has entered into a definitive agreement to acquire Allergan Biologics Limited (ABL) in Liverpool, UK, for $118.7 million from AbbVie.
Microbial contract biomanufacturing market to be worth $9.3 billion by 2030 europeanpharmaceuticalreview
November 18, 2020
A new analysis suggests that Europe and North America will capture more than 80 percent of the $9.3 billion market by 2030.
CCRM, MIP Partner to Build Biomanufacturing Campus contractpharma
November 16, 2020
Aims to establish CDMO ops focused on regenerative medicine-based technologies and cell and gene therapies.
COVID-19 therapeutics to rely on large-scale biomanufacturing reactors, report says europeanpharmaceuticalreview
November 12, 2020
A new report has found that if COVID-19 biologics are approved, it could apply pressure to the global biomanufacturing capacity.